Oak Longevity vs Sesame Care: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Sesame Care beats Oak Longevity overall, scoring 7.9/10 vs 7.5/10. Sesame Care is more affordable at $59/mo vs $130/mo. Choose Oak Longevity for budget-conscious users who want one of the cheapest compound. Choose Sesame Care for users who want cheap fda-approved brand-name glp-1 access ($.
A side-by-side comparison of Oak Longevity and Sesame Care covering pricing, scores, medication types, insurance, and more to help you decide.
Oak Longevity
#23 of 42Telehealth platform offering compounded semaglutide and tirzepatide at the lower end of market pricing, alongside an oral Wegovy option, brand-name FDA-approved GLP-1s, and a longevity stack (NAD+, Glutathione, Sermorelin, Tesamorelin). Distinctive non-subscription billing — patients pay each month manually rather than auto-renew.
Visit Oak LongevitySesame Care
#10 of 42Telehealth marketplace offering both a low-cost consultation model ($25/visit) and the new Success by Sesame membership program ($59/mo on 3/6/12-month plans) that bundles FDA-approved brand-name GLP-1 medications — including Foundayo (orforglipron), Wegovy pen and pill, and Zepbound.
Visit Sesame Care| Feature | Oak Longevity | Sesame Care |
|---|---|---|
| Our Score | 7.5/10 | 7.9/10 |
| Starting Price | $130/mo | $59/mo |
| Medication Type | Both | Both |
| Insurance Accepted | No | Yes |
| Best For | Budget-conscious users who want one of the cheapest compounded GLP-1 entries plus a no-subscription billing model and a longevity-stack add-on (NAD+, Sermorelin) | Users who want cheap FDA-approved brand-name GLP-1 access ($149-349/mo Wegovy and Zepbound via Success by Sesame), or insured patients who just need a prescriber |
| Ranking | #23 | #10 |
Pros & Cons Compared
Oak Longevity
Pros
- +$130/mo for compounded semaglutide is among the cheapest entries on the market — Sprout Health ($99) and Sesame Care ($99) are lower, but Oak undercuts most mid-tier platforms
- +Compounded tirzepatide at $199/mo is competitively priced for a GLP-1+GIP dual agonist
- +No-subscription model — patients are not auto-charged each month, choose to renew manually. Reduces unwanted recurring charges
- +Broadest medication mix on the platform: compounded sema + tirz, oral Wegovy, brand Wegovy/Ozempic/Zepbound/Mounjaro, plus longevity peptides (NAD+, Glutathione, Sermorelin, Tesamorelin)
- +Money-back guarantee if not approved by physician — useful safety net for borderline-eligibility patients
- +Free shipping and free health coaching included in every program
Cons
- −Brand-name pricing ($1,200-$1,500/mo) is significantly above market — NovoCare direct pricing for Wegovy is $349/mo, LillyDirect Zepbound $299/mo. Never buy brand-name through Oak
- −No published lab panels, no specialty (obesity medicine) physicians disclosed — clinical depth is shallow
- −'Up to 50% cheaper than competitors' marketing claim is unverified and inconsistent — depends on which competitor and which medication tier
- −'Longevity' framing pushes users toward add-on products (NAD+, Sermorelin, Tesamorelin) that have limited clinical evidence for weight loss specifically
- −Newer brand without disclosed company history, founding date, or executive team on landing pages
- −Three-month plans are billed upfront — pricing transparency is good, but commit-up-front is a friction point for users testing the platform
Sesame Care
Pros
- +Success by Sesame program launched 2026 — $59/mo on a 3/6/12-month plan, bundles labs, unlimited messaging, and provider choice
- +Brand-name cash pricing is competitive — Wegovy pen $199 intro / $349 ongoing, Zepbound vial $299, Wegovy pill $149
- +Foundayo (Lilly's FDA-approved oral GLP-1) available as of April 2026 at $149/mo
- +Original pay-per-visit model still available at $25/consultation for users who just need a prescriber
Cons
- −Membership model adds complexity — two distinct products (pay-per-visit vs Success membership) can be confusing
- −Success by Sesame requires a 3-month minimum commitment to hit the $59/mo rate
- −Compounded meds are de-emphasized on the current marketing — focus has shifted to FDA-approved brand-name paths
- −Less hand-holding than dedicated subscription platforms like Willow or Eden Health
Our Verdict
Sesame Care edges out Oak Longevity with a score of 7.9/10 vs 7.5/10. If budget is your priority, Sesame Care starts at $59/mo compared to Oak Longevity's $130/mo. Sesame Care accepts insurance, which can significantly reduce your out-of-pocket costs. Choose Oak Longevity if you want: budget-conscious users who want one of the cheapest compounded glp-1 entries plus a no-subscription billing model and a longevity-stack add-on (nad+, sermorelin). Choose Sesame Care if you want: users who want cheap fda-approved brand-name glp-1 access ($149-349/mo wegovy and zepbound via success by sesame), or insured patients who just need a prescriber.